D25 - What’s new in industry & science? Part 2

Lomond Auditorium

The FIP Industrial Pharmacy Section and all special interest groups


Takuya Kumamoto (Hiroshima University, Japan) and Amanda Corbett (UNC Eshelman School of Pharmacy, USA)


  1. 09:00 – 09:10 Identification and characterization of 6 synthetic cannabinoid agonists by NMR and UHPLC-QTOF/MS/MS
    Husain Naqi (University of Bath, UK)
  2. 09:10 – 09:20 Analysis tamoxifen, endoxifen, and 4-hydroxytamoxifen in DBS of breast cancer patients by LC-MS/MS
    Yahdiana Harahap (Universitas Indonesia, Indonesia)
  3. 09:20 – 09:30 Downregulation of mir-133b-5p by rest promotes prostate cancer metastasis to bone by targeting TGF
    Yubo Tang (Department of Pharmacy, The First Affiliated Hospital, Sun Yat-sen University, China)
  4. 09:30 – 09:40 Hyaluronic acid conjugated multi walled carbon nanotubes for colon cancer targeting
    Ashish Jain (Adina Institute of Pharmaceutical Sciences Sagar M.P., India)
  5. 09:40 – 09:50 Establishment of drug release determination method for Nestorone intravaginal ring
    Meiying Ning (National Research Institute for Family Planning, China)
  6. 09:50 – 10:00 Radiation engineered functional nanogels as therapeutic and diagnostic imaging agent
    Siti Janib (MNA, Malaysia)
  7. 10:00 – 10:10 Formulation and evaluation of polymer free in-situ forming vesicles
    Nada El Hoffy (Future University, Egypt)
  8. 10:10 – 10:20 The mechanism of acute promyelocytic leukemia treatment using the Realgar-Indigo Naturalis formula
    Xiaobo Wang (Beihai Hospital, China)

10:20 – 10:40 Coffee/tea break

  1. 10:40 – 10:50 Measurement of infliximab and anti-drug antibody levels in patients with inflammatory bowel disease
    Sho Masui (Kyoto University Hospital, Japan)
  2. 10:50 – 11:00 Impact of pear1 gene polymorphisms on clinical outcomes of Chinese acute coronary syndrome patients
    Xiaoyan Nie (Peking University Health Science Center, China)
  3. 11:00 -11:10 Pharmacists identification of counterfeit drugs and perceptions of stakeholders’ partnership in Egypt
    Amira Bashir (Faculty of Pharmacy, Alexandria University, Egypt)
  4. 11:10 -11:20 Assessment of non-adherence factors using original score sheets in Setsuyaku-bag campaign of Japan
    Takao Shimazoe (Department of Clinical Pharmacy and Pharmaceutical Care, Graduate School of Pharmaceutical Sciences, Japan)
  5. 11:20 – 11:30 Barriers and facilitators to deprescribing inappropriate medicines in long-term care facilities
    Emma Bolton (University of Leeds, UK)
  6. 11:30 – 11:40 The non-medical prescribers’ opinions and beliefs of non-medical prescribing practice in oncology
    Sophie Harding (Velindre Cancer Centre, UK)
  7. 11:40 – 11:50 Exploring accredited pharmacists’ pharmacovigilance work processes during home medicines reviews
    Marea Patounas (Queensland University of Technology, Australia)
  8. 11:50 – 12:00 Making every opportunity count – What do student pharmacists need to know?
    Myra Mackenzie (Robert Gordon University, UK)
  9. 12:00 – 12:10 The impact of drugs on the environment: What do pharmacists and technicians believe?
    Judith Singleton (Queensland University of Technology, Australia)
  10. 12:10 – 12:20 The role of pharmacy in integrated urgent & emergency care / NHS 111 Yorkshire Ambulance Service
    Usha Kaushal (NHS 111 Yorkshire Ambulance Service, UK)

12:20 – 12:30 
Q & A and conclusions by the chair